Could a daily sip of carbon monoxide ease sickle cell pain?
Disease control
Recruiting now
This early-stage clinical trial is testing the safety and effects of an experimental oral liquid containing carbon monoxide (HBI-002) in people with sickle cell disease. Participants aged 14-55 will take the liquid daily for 14 days. Researchers will monitor side effects, measure…
Phase: PHASE1, PHASE2 • Sponsor: Hillhurst Biopharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC